Home » Doctor Blog » Archives for January 2014

Month: January 2014

Arthritis Pain by Barbro Brost D.C.

plymouth's #1 chiropractor
Dr. Barbro Brost

A recent article in Medscape Rheumatology (9.25.13) found an increase in use of complementary and alternative medicine (CAM) for relief of arthritis pain, in comparison to lifestyle modification and pharmacotherapy. Among CAM options available, chiropractic care is documented as one of the most popular among consumers, according to research published in the Annals of Internal Medicine.

Nathan Wei MC, rheumatologist, has noted that in many cases Doctors of Chiropractic are more knowledgeable about the musculoskeletal system than other health care providers.

Chiropractors treat arthritis differently than the common medical approach of pain pills and anti-inflammatory medication, that all cause long term negative and often dangerous side effects. Instead of masking or suppressing the symptoms of arthritis, our doctors at The Brost Clinic look for the cause and correct that.

Basically there are two main types of arthritis, the “wear and tear” type (osteoarthritis or degenerative arthritis) and inflammatory arthritis (rheumatoid, etc.) Arthritis in the spine develops in joints that are misaligned for a period of time or from uncorrected trauma to the spine such as an untreated whiplash injury. This type of arthritis can be treated very effectively with chiropractic adjustments.

Inflammatory arthritis also responds well to chiropractic adjustments but warrants further investigation to determine the cause. Diet changes and nutritional supplements are often required in conjunction with chiropractic care.

Acupuncture is a good compliment to chiropractic care and massage therapy can also be helpful. The Brost Clinic has expertise in all of these treatments and can tailor the most effective treatment plan for each patient, to alleviate the gradual worsening symptoms of arthritis, by correcting the cause instead of just masking the symptoms.

If you or anyone you care about suffers from arthritis, call today to schedule an appointment!

-Dr. Barbro Brost

Vitamin B And Folic Acid May Reduce Risk Of Age-Related Vision Loss

Taking a combination of vitamins B6 and B12 and folic acid appears to decrease the risk of age-related macular degeneration in women, according to a report in the February 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Age-related macular degeneration (AMD) is a leading cause of vision loss in older Americans, according to background information in the article. Treatment options exist for those with severe cases of the disease, but the only known prevention method is to avoid smoking. Recent studies have drawn a connection between AMD and blood levels of homocysteine, an amino acid. High levels of homocysteine are associated with dysfunction of the blood vessel lining, whereas treatment with vitamin B6, vitamin B12 and folic acid appears to reduce homocysteine levels and may reverse this blood vessel dysfunction.

William G. Christen, Sc.D., of Brigham and Women’s Hospital and Harvard Medical School, Boston, and colleagues conducted a randomized, double-blind clinical trial involving 5,442 women age 40 and older who already had heart disease or at least three risk factors. Of these, 5,205 did not have AMD at the beginning of the study. In April 1998, these women were randomly assigned to take a placebo or a combination of folic acid (2.5 milligrams per day), pyridoxine hydrochloride (vitamin B6, 50 milligrams per day) and cyanocobalamin (vitamin B12, 1 milligram per day). Participants continued the therapy through July 2005 and were tracked for the development of AMD through November 2005.

Over an average of 7.3 years of treatment and follow-up, 137 new cases of AMD were documented, including 70 cases that were visually significant (resulting in a visual acuity of 20/30 or worse). Of these, 55 AMD cases, 26 visually significant, occurred in the 2,607 women in the active treatment group, whereas 82 of the 2,598 women in the placebo group developed AMD, 44 cases of which were visually significant. Women taking the supplements had a 34 percent lower risk of any AMD and a 41 percent lower risk of visually significant AMD. “The beneficial effect of treatment began to emerge at approximately two years of follow-up and persisted throughout the trial,” the authors write.

“The trial findings reported herein are the strongest evidence to date in support of a possible beneficial effect of folic acid and B vitamin supplements in AMD prevention,” the authors write. Because they apply to the early stages of disease development, they appear to represent the first identified way—other than not smoking—to reduce the risk of AMD in individuals at an average risk. “From a public health perspective, this is particularly important because persons with early AMD are at increased risk of developing advanced AMD, the leading cause of severe, irreversible vision loss in older Americans.”

Beyond lowering homocysteine levels, potential mechanisms for the effectiveness of B vitamins and folic acid in preventing AMD include antioxidant effects and improved function of blood vessels in the eye, they note.

This study was supported by grants from the National Heart, Lung and Blood Institute and from the National Eye Institute. Vitamin E and its placebo were provided by the Cognis Corporation. All other agents and their placebos were provided by BASF corporation.

Source:  William G. Christen; Robert J. Glynn; Emily Y. Chew; Christine M. Albert; JoAnn E. Manson. Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women: The Women’s Antioxidant and Folic Acid Cardiovascular Study. Archives of Internal Medicine, 2009; 169 (4): 335 DOI: 10.1001/archinternmed.2008.574